Rossetti AO, Lowenstein DH (2011) Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol 10(10):922–930
Article PubMed PubMed Central Google Scholar
Ascoli M, Ferlazzo E, Gasparini S, Mastroianni G, Citraro R, Roberti R et al (2021) Epidemiology and outcomes of status epilepticus. Int J Gen Med 14:2965–2973
Article PubMed PubMed Central Google Scholar
Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J et al (2016) Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr 16(1):48–61
Article PubMed PubMed Central Google Scholar
Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T et al (2012) Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 17(1):3–23
Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S et al (2015) A definition and classification of status epilepticus—Report of the ILAE task force on classification of status epilepticus. Epilepsia 56(10):1515–1523
Alvarez V, Westover MB, Drislane FW, Dworetzky BA, Curley D, Lee JW et al (2014) Evaluation of a clinical tool for early etiology identification in status epilepticus. Epilepsia 55(12):2059–2068
Article PubMed PubMed Central Google Scholar
Wasterlain CG, Fujikawa DG, Penix L, Sankar R (1993) Pathophysiological mechanisms of brain damage from status epilepticus. Epilepsia 34(s1):S37–S53
Meldrum BS, Horton RW (1973) Physiology of status epilepticus in primates. Arch Neurol 28(1):1–9
Article CAS PubMed Google Scholar
Fernández IS, Goodkin HP, Scott RC (2019) Pathophysiology of convulsive status epilepticus. Seizure 68:16–21
Meldrum BS, Brierley JB (1973) Prolonged epileptic seizures in primates: Ischemic cell change and its relation to ictal physiological events. Arch Neurol 28(1):10–17
Article CAS PubMed Google Scholar
Lipton SA, Rosenberg PA (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330(9):613–622
Article CAS PubMed Google Scholar
Trinka E, Höfler J, Zerbs A (2012) Causes of status epilepticus. Epilepsia 53(s4):127–138
Meierkord H, Holtkamp M (2007) Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 6(4):329–339
Shorvon S, Ferlisi M (2012) The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 135(8):2314–2328
Eugen T, Reetta K (2017) 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure 44:65–73
Knake S, Rosenow F, Vescovi M, Oertel WH, Mueller HH, Wirbatz A et al (2001) Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia 42(6):714–718
Article CAS PubMed Google Scholar
Neligan A, Shorvon SD (2010) Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol 67(8):931–940
Leitinger M, Trinka E, Giovannini G, Zimmermann G, Florea C, Rohracher A et al (2019) Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes. Epilepsia 60(1):53–62
Hirsch LJ, Gaspard N, van Baalen A, Nabbout R, Demeret S, Loddenkemper T et al (2018) Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 59(4):739–744
Tharmaraja T, Ho JSY, Neligan A, Rajakulendran S (2023) The etiology and mortality of new-onset refractory status epilepticus (NORSE) in adults: a systematic review and meta-analysis. Epilepsia 64(5):1113–1124
Gaspard N, Foreman BP, Alvarez V, Cabrera Kang C, Probasco JC, Jongeling AC et al (2015) New-onset refractory status epilepticus: etiology, clinical features, and outcome. Neurology 85(18):1604–1613
Article PubMed PubMed Central Google Scholar
Hocker SE (2015) Status Epilepticus. Continuum 21(5):1362–1383
Outin H, Guèye P, Alvarez V, Auvin S, Clair B, Convers P et al (2020) Prise en charge des états de mal épileptiques en préhospitalier, en structure d’urgence et en réanimation dans les 48 premières heures (à l’exclusion du nouveau-né et du nourrisson). Méd Intensive Réanim 29(3):135–172
Mendes A, Sampaio L (2016) Brain magnetic resonance in status epilepticus: a focused review. Seizure 38:63–67
Requena M, Sarria-Estrada S, Santamarina E, Quintana M, Sueiras M, Rovira A et al (2019) Peri-ictal magnetic resonance imaging in status epilepticus: temporal relationship and prognostic value in 60 patients. Seizure 71:289–294
Tumani H, Jobs C, Brettschneider J, Hoppner AC, Kerling F, Fauser S (2015) Effect of epileptic seizures on the cerebrospinal fluid—A systematic retrospective analysis. Epilepsy Res 114:23–31
Article CAS PubMed Google Scholar
Bauer G, Trinka E (2010) Nonconvulsive status epilepticus and coma. Epilepsia 51(2):177–190
Tan THL, Perucca P, O’Brien TJ, Kwan P, Monif M (2021) Inflammation, ictogenesis, and epileptogenesis: an exploration through human disease. Epilepsia 62(2):303–324
Lattanzi S, Leitinger M, Rocchi C, Salvemini S, Matricardi S, Brigo F et al (2022) Unraveling the enigma of new-onset refractory status epilepticus: a systematic review of aetiologies. Eur J Neurol 29(2):626–647
Spatola M, Novy J, Pasquier RD, Dalmau J, Rossetti AO (2015) Status epilepticus of inflammatory etiology: a cohort study. Neurology 85(5):464–470
Article PubMed PubMed Central Google Scholar
Trinka E, Höfler J, Leitinger M, Brigo F (2015) Pharmacotherapy for status epilepticus. Drugs 75:1499–1521
Article CAS PubMed PubMed Central Google Scholar
Arya R, Rotenberg A (2019) Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus. Seizure 68:89–96
Kienitz R, Kay L, Beuchat I, Gelhard S, von Brauchitsch S, Mann C et al (2022) Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs 36(9):951–975
Article CAS PubMed PubMed Central Google Scholar
Silbergleit R, Lowenstein D, Durkalski V, Conwit R (2011) RAMPART (rapid anticonvulsant medication prior to arrival trial): a double-blind randomized clinical trial of the efficacy of IM midazolam versus IV lorazepam in the pre-hospital treatment of status epilepticus by paramedics. Epilepsia 52(Suppl 8):45–47
Article CAS PubMed PubMed Central Google Scholar
Prasad M, Krishnan PR, Sequeira R, Al-Roomi K (2014) Anticonvulsant therapy for status epilepticus. Cochrane Database Syst Rev 9:CD3723
Alvarez V, Lee JW, Drislane FW, Westover MB, Novy J, Dworetzky BA et al (2015) Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison. Epilepsia 56(8):1275–1285
Article CAS PubMed PubMed Central Google Scholar
Navarro V, Dagron C, Elie C, Lamhaut L, Demeret S, Urien S et al (2016) Prehospital treatment with levetiracetam plus clonazepam or placebo plus clonazepam in status epilepticus (SAMUKeppra): a randomised, double-blind, phase 3 trial. Lancet Neurol 15(1):47–55
Article CAS PubMed Google Scholar
Kellinghaus C, Rossetti AO, Trinka E, Lang N, May TW, Unterberger I et al (2019) Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE). Ann Neurol 85(3):421–432
Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D et al (2019) Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med 381(22):2103–2113
留言 (0)